Picture of Captor Therapeutics SA logo

CTX Captor Therapeutics SA News Story

0.000.00%
pl flag iconLast trade - 00:00
HealthcareSpeculativeSmall CapMomentum Trap

Brief: Captor Therapeutics Ends Dispute With Poland's National Centre For R&D

May 27 (Reuters) - Captor Therapeutics SA CTXP.WA:

ENDS DISPUTE WITH POLAND'S NATIONAL CENTRE FOR RESEARCH AND DEVELOPMENT

COMPANY TO DISSOLVE PLN 7.9 MILLION PROVISION

COMPANY HAS RETURNED PLN 4.1 MILLION THAT IT RECEIVED AS FUNDING FOR CT-02 PROJECT

COMPANY TO PAY ABOUT PLN 1.3 MILLION IN INTEREST

COMPANY WILL APPLY FOR REDUCTION IN INTEREST AMOUNT

COMPANY WILL SHOW OTHER OPERATING INCOME OF PLN 2.5 MILLION WHICH WILL BE RECOGNIZED IN Q2 RESULTS

INTENDS TO DEVELOP CT-02B AND CT-02S PROJECTS, WHICH ARE CONTINUATION OF CT-02 PROJECT

Source text: ID:nEM6C4JBFa

Further company coverage: CTXP.WA

 (Gdansk Newsroom)

 ((gdansk.newsroom@thomsonreuters.com; +48 58 769 66 00;))

Recent news on Captor Therapeutics SA

See all news